Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Abstract

Many bacterial pathogens secrete potent toxins to aid in the destruction of host tissue, to initiate signaling changes in host cells or to manipulate immune system responses during the course of infection. Though methods have been developed to successfully purify and produce many of these important virulence factors, there are still many bacterial toxins whose unique structure or extensive post-translational modifications make them difficult to purify and study in in vitro systems. Furthermore, even when pure toxin can be obtained, there are many challenges associated with studying the specific effects of a toxin under relevant physiological conditions. Most in vitro cell culture models designed to assess the effects of secreted bacterial toxins on host cells involve incubating host cells with a one-time dose of toxin. Such methods poorly approximate what host cells actually experience during an infection, where toxin is continually produced by bacterial cells and allowed to accumulate gradually during the course of infection. This protocol describes the design of a permeable membrane insert-based bacterial infection system to study the effects of Streptolysin S, a potent toxin produced by Group A Streptococcus, on human epithelial keratinocytes. This system more closely mimics the natural physiological environment during an infection than methods where pure toxin or bacterial supernatants are directly applied to host cells. Importantly, this method also eliminates the bias of host responses that are due to direct contact between the bacteria and host cells. This system has been utilized to effectively assess the effects of Streptolysin S (SLS) on host membrane integrity, cellular viability, and cellular signaling responses. This technique can be readily applied to the study of other secreted virulence factors on a variety of mammalian host cell types to investigate the specific role of a secreted bacterial factor during the course of infection.

Novel Insights on Plant Extracts to Prevent and Treat Recurrent Urinary Tract Infections

“…This is why advanced urothelial models will benefit from platforms that have porous substrates. The most straightforward implementation would be a transwell system or similar permeable membrane systems [29]. The volume of urine added, the possibility to change urine concentrations over time, and donor characteristics are considered factors (sex, age, and any diseases or disorders that could alter the urine's composition).…”

“…These herbs contain highly active berberine alkaloid compounds (berberine, coptisine, and palmatine) with specific inhibitory activity against E. coli [13]. Antimicrobial substances from Salvia plebeia, a native herb from Asia, have been shown to inhibit the growth of E. coli at a minimal inhibitory concentration of 0.25 g/mL [29]. Moreover, several clinical trials havee proven that adding Chinese herbs to antibiotic prophylaxis is more effective in reducing rUTI rates, especially in postmenopausal women, but more extensive randomized trials are required.…”

TheAchromobacterType 3 secretion system drives pyroptosis and immunopathology via independent activation of NLRC4 and NLRP3 inflammasomes

“…Although we washed bacteria repeatedly before suspension in RPMI to remove effectors in the culture media, it was possible that bacteria could secrete more effectors during infection. To circumnavigate these issues, we used transwells 31 to demonstrate whether bacteria-cell contact was required to induce cytotoxicity. As shown in Figure S1A, Achromobacter must be in contact with macrophages to cause cytotoxicity as LDH release is abrogated in the transwells.…”